Inflammatory cascade response to toxin release: Therapeutic perspectives;Cascade inflammatoire en réponse la libération de toxines. Perspectives thérapeutiques

Annales Pharmaceutiques Francaises

Volumn 59, Issue 3, 2001, Pages 191-197

  Bohuon, Cl ^a  

^a NONE   (France)

Author keywords

Cytokinine cascade; Endotoxins; Therapeutics

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HAPTOGLOBIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCLONAL ANTIBODY; PROCALCITONIN; SELECTIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE PHASE RESPONSE; BACTERIAL INFECTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MULTICENTER STUDY; NONHUMAN; SEPSIS; SEPTIC SHOCK;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; TOXINS, BIOLOGICAL;

EID: 0034993264     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. 14 mediated signaling of human leucocytes by E. Coli can be mediated by interaction of whole bacteria and host cells
2. 14 and the immune response to LPS
3. 1 βeta and E. coli
4. CpG motifs in bacterial DNA trigger direct β-cell activation
5. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease
6. 2′, a TNFα promoter polymorphism, with septic shock susceptibility and mortality
7. 1 receptor/toll-like receptor superfamily: Crucial receptors for inflammation and host defense
8. Circulating complement proteins in multiple trauma patients. Correlation with injure severity development of sepsis, and outcome
9. Les cytokines
10. Protection from septic shock by neutralization of macrophage inhibitory factor
11. High serum procalcitonin concentrations in patients with sepsis and infection
12. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis
13. Mechanisms of disease: Acute phase proteins and other systemic responses to inflammation
14. Mab to humor TNF α. Efficacy and safety in patients with the sepsis syndrome
15. An international multicenter, placebo-controlled trial of Mab to human tumor necrosis factor in patients with sepsis (Intersept Study Group)
16. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome
17. Vagus nerve stimulation attenuates the systemic inflammatory responses to endotoxin